Public signalCompany raiseAuto-indexed · Unverified
Immunovant, Inc. raised $450.0M
Immunovant, Inc.· NEW YORK, US· Pharmaceuticals· Filed Jan 21, 2025
Immunovant, Inc. reported raising capital. Based in NEW YORK, NEW YORK, US. First sale reported 2025-01-15. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$450.0M
Confidence90%
Raised
$450.0M
Investors
11
Jurisdiction
DELAWARE
On the record
- Location
- NEW YORK, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $450.0M
- Target amount
- $450.0M
- Filing date
- Jan 21, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Pharmaceuticals
- Number of investors
- 11
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $450.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Andrew Fromkin
Director
New York, US
Atul Pande
Director
New York, US
Bill Macias
Executive Officer
New York, US
Christopher Van Tuyl
Executive Officer
New York, US
Douglas Hughes
Director
New York, US
Eric Venker
Director
New York, US
Eva Renee Barnett
Executive Officer
New York, US
Frank Torti
Director
New York, US
George Migausky
Director
New York, US
Jay Stout
Executive Officer
New York, US
Melanie Gloria
Executive Officer
New York, US
Michael Geffner
Executive Officer
New York, US
Pete Salzmann
Executive Officer
New York, US
Sources & provenance
“Operating company sold 450,000,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 21, 2025. Details beyond the filing have not been verified.
Tags
USCompanyPharmaceuticalsOver $100MCompany Raise
Are you associated with Immunovant, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record